Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease.

Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease.
复制标题

超型 HLA 遗传标记患病率的种族差异对于慢性铍病易感性就业前测试并不重要。

DOI:
10.1002/ajim.10072
复制
发表时间:
2002
影响因子:
3.5
通讯作者:
E. McCanlies
E. McCanlies
中科院分区:
医学4区
文献类型:
--
作者:
A. Weston;James S Ensey;K. Kreiss;C. Keshava;E. McCanlies

文献摘要

参考文献

被引文献

相似文献

背景
BACKGROUND A beryllium materials manufacturer is conducting a limited pilot program that offers testing for HLA-DP beta 1E69 with genetic counseling through a third party to applicants for employment. An important consideration in this regard is the prevalence of this marker in the general population, and its consequent positive predictive value of disease susceptibility. METHODS Polymerase chain reaction and restriction fragment length polymorphism analyses were used to determine HLA-DP beta 1E69 population frequencies. Estimation of positive predictive values assumed a disease frequency among beryllium workers of either 5 or 15% and used an odds ratio for disease risk of 35 for the HLA-DP beta 1E69 marker. RESULTS Allelic/carrier frequencies were found to be 0.21/0.33, 0.24/0.40, 0.27/0.47, and 0.38/0.59 for Caucasians, African-Americans, Hispanics, and Chinese, respectively. Ranges of positive predictive values for a genetic test based on HLA-DP beta 1E69 in these populations were calculated to be 8.3-14.3% for carriers with an assumed disease frequency of 5%. For high risk subgroups with disease frequencies of 15%, the range of positive predictive values was found to span between 24.9-43.0%. CONCLUSIONS These estimates suggest that using HLA-DP beta 1E69 genotyping for general pre-employment screening in the beryllium industry has a low positive predictive value, which varies little among racial groups where carrier frequencies differ significantly.
HLA II 类区域内的遗传多样性:十个新的 DPB1 等位基因及其群体分布。
DOI: 10.1111/j.1399-0039.1992.tb02109.x
发表时间: 1992
期刊: Tissue antigens
影响因子: --
作者:
Moonsamy,PV;Suraj,VC;Bugawan,TL;Saiki,RK;Stoneking,M;Roudier,J;Magzoub,MM;Hill,AV;Begovich,AB
通讯作者: Begovich,AB
铍敏感性与 HLA-DP 基因型相关。
DOI: 10.1016/s0300-483x(01)00410-3
发表时间: 2001
期刊: Toxicology
影响因子: 4.5
作者:
Wang,Z;Farris,GM;Newman,LS;Shou,Y;Maier,LA;Smith,HN;Marrone,BL
通讯作者: Marrone,BL